1 Market Overview

1.1 Product Overview and Scope of Radiopharmaceutical Therapy

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Radiopharmaceutical Therapy by Type

1.3.1 Overview: Global Radiopharmaceutical Therapy Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Radiopharmaceutical Therapy Consumption Value Market Share by Type in 2022

1.3.3 Actinium-225

1.3.4 Lutetium-177

1.3.5 Radium-223

1.3.6 Holmium-166

1.3.7 Other

1.4 Global Radiopharmaceutical Therapy Market by Application

1.4.1 Overview: Global Radiopharmaceutical Therapy Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Oncology

1.4.3 Cardiology

1.4.4 Other

1.5 Global Radiopharmaceutical Therapy Market Size & Forecast

1.6 Global Radiopharmaceutical Therapy Market Size and Forecast by Region

1.6.1 Global Radiopharmaceutical Therapy Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Radiopharmaceutical Therapy Market Size by Region, (2018-2029)

1.6.3 North America Radiopharmaceutical Therapy Market Size and Prospect (2018-2029)

1.6.4 Europe Radiopharmaceutical Therapy Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Radiopharmaceutical Therapy Market Size and Prospect (2018-2029)

1.6.6 South America Radiopharmaceutical Therapy Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Radiopharmaceutical Therapy Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Bracco Imaging

2.1.1 Bracco Imaging Details

2.1.2 Bracco Imaging Major Business

2.1.3 Bracco Imaging Radiopharmaceutical Therapy Product and Solutions

2.1.4 Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Bracco Imaging Recent Developments and Future Plans

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business

2.2.3 Bayer Radiopharmaceutical Therapy Product and Solutions

2.2.4 Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Bayer Recent Developments and Future Plans

2.3 Mallinckrodt

2.3.1 Mallinckrodt Details

2.3.2 Mallinckrodt Major Business

2.3.3 Mallinckrodt Radiopharmaceutical Therapy Product and Solutions

2.3.4 Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Mallinckrodt Recent Developments and Future Plans

2.4 Nordion

2.4.1 Nordion Details

2.4.2 Nordion Major Business

2.4.3 Nordion Radiopharmaceutical Therapy Product and Solutions

2.4.4 Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Nordion Recent Developments and Future Plans

2.5 Triad Isotopes

2.5.1 Triad Isotopes Details

2.5.2 Triad Isotopes Major Business

2.5.3 Triad Isotopes Radiopharmaceutical Therapy Product and Solutions

2.5.4 Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Triad Isotopes Recent Developments and Future Plans

2.6 Lantheus

2.6.1 Lantheus Details

2.6.2 Lantheus Major Business

2.6.3 Lantheus Radiopharmaceutical Therapy Product and Solutions

2.6.4 Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Lantheus Recent Developments and Future Plans

2.7 IBA Group

2.7.1 IBA Group Details

2.7.2 IBA Group Major Business

2.7.3 IBA Group Radiopharmaceutical Therapy Product and Solutions

2.7.4 IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 IBA Group Recent Developments and Future Plans

2.8 GE Healthcare

2.8.1 GE Healthcare Details

2.8.2 GE Healthcare Major Business

2.8.3 GE Healthcare Radiopharmaceutical Therapy Product and Solutions

2.8.4 GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 GE Healthcare Recent Developments and Future Plans

2.9 China Isotope & Radiation

2.9.1 China Isotope & Radiation Details

2.9.2 China Isotope & Radiation Major Business

2.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Product and Solutions

2.9.4 China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 China Isotope & Radiation Recent Developments and Future Plans

2.10 Jubilant Pharma

2.10.1 Jubilant Pharma Details

2.10.2 Jubilant Pharma Major Business

2.10.3 Jubilant Pharma Radiopharmaceutical Therapy Product and Solutions

2.10.4 Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Jubilant Pharma Recent Developments and Future Plans

2.11 Eli Lilly

2.11.1 Eli Lilly Details

2.11.2 Eli Lilly Major Business

2.11.3 Eli Lilly Radiopharmaceutical Therapy Product and Solutions

2.11.4 Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Eli Lilly Recent Developments and Future Plans

2.12 Advanced Accelerator Applications

2.12.1 Advanced Accelerator Applications Details

2.12.2 Advanced Accelerator Applications Major Business

2.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Product and Solutions

2.12.4 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Advanced Accelerator Applications Recent Developments and Future Plans

2.13 SIEMENS

2.13.1 SIEMENS Details

2.13.2 SIEMENS Major Business

2.13.3 SIEMENS Radiopharmaceutical Therapy Product and Solutions

2.13.4 SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 SIEMENS Recent Developments and Future Plans

2.14 Dongcheng

2.14.1 Dongcheng Details

2.14.2 Dongcheng Major Business

2.14.3 Dongcheng Radiopharmaceutical Therapy Product and Solutions

2.14.4 Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 Dongcheng Recent Developments and Future Plans

2.15 Navidea

2.15.1 Navidea Details

2.15.2 Navidea Major Business

2.15.3 Navidea Radiopharmaceutical Therapy Product and Solutions

2.15.4 Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 Navidea Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Radiopharmaceutical Therapy Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Radiopharmaceutical Therapy by Company Revenue

3.2.2 Top 3 Radiopharmaceutical Therapy Players Market Share in 2022

3.2.3 Top 6 Radiopharmaceutical Therapy Players Market Share in 2022

3.3 Radiopharmaceutical Therapy Market: Overall Company Footprint Analysis

3.3.1 Radiopharmaceutical Therapy Market: Region Footprint

3.3.2 Radiopharmaceutical Therapy Market: Company Product Type Footprint

3.3.3 Radiopharmaceutical Therapy Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Radiopharmaceutical Therapy Consumption Value and Market Share by Type (2018-2023)

4.2 Global Radiopharmaceutical Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Radiopharmaceutical Therapy Consumption Value Market Share by Application (2018-2023)

5.2 Global Radiopharmaceutical Therapy Market Forecast by Application (2024-2029)

6 North America

6.1 North America Radiopharmaceutical Therapy Consumption Value by Type (2018-2029)

6.2 North America Radiopharmaceutical Therapy Consumption Value by Application (2018-2029)

6.3 North America Radiopharmaceutical Therapy Market Size by Country

6.3.1 North America Radiopharmaceutical Therapy Consumption Value by Country (2018-2029)

6.3.2 United States Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

6.3.3 Canada Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

6.3.4 Mexico Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Radiopharmaceutical Therapy Consumption Value by Type (2018-2029)

7.2 Europe Radiopharmaceutical Therapy Consumption Value by Application (2018-2029)

7.3 Europe Radiopharmaceutical Therapy Market Size by Country

7.3.1 Europe Radiopharmaceutical Therapy Consumption Value by Country (2018-2029)

7.3.2 Germany Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

7.3.3 France Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

7.3.5 Russia Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

7.3.6 Italy Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region

8.3.1 Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Region (2018-2029)

8.3.2 China Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

8.3.3 Japan Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

8.3.4 South Korea Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

8.3.5 India Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

8.3.7 Australia Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

9 South America

9.1 South America Radiopharmaceutical Therapy Consumption Value by Type (2018-2029)

9.2 South America Radiopharmaceutical Therapy Consumption Value by Application (2018-2029)

9.3 South America Radiopharmaceutical Therapy Market Size by Country

9.3.1 South America Radiopharmaceutical Therapy Consumption Value by Country (2018-2029)

9.3.2 Brazil Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

9.3.3 Argentina Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country

10.3.1 Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Country (2018-2029)

10.3.2 Turkey Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

10.3.4 UAE Radiopharmaceutical Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Radiopharmaceutical Therapy Market Drivers

11.2 Radiopharmaceutical Therapy Market Restraints

11.3 Radiopharmaceutical Therapy Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Radiopharmaceutical Therapy Industry Chain

12.2 Radiopharmaceutical Therapy Upstream Analysis

12.3 Radiopharmaceutical Therapy Midstream Analysis

12.4 Radiopharmaceutical Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Radiopharmaceutical Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Radiopharmaceutical Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Radiopharmaceutical Therapy Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Radiopharmaceutical Therapy Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Bracco Imaging Company Information, Head Office, and Major Competitors

Table 6. Bracco Imaging Major Business

Table 7. Bracco Imaging Radiopharmaceutical Therapy Product and Solutions

Table 8. Bracco Imaging Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Bracco Imaging Recent Developments and Future Plans

Table 10. Bayer Company Information, Head Office, and Major Competitors

Table 11. Bayer Major Business

Table 12. Bayer Radiopharmaceutical Therapy Product and Solutions

Table 13. Bayer Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Bayer Recent Developments and Future Plans

Table 15. Mallinckrodt Company Information, Head Office, and Major Competitors

Table 16. Mallinckrodt Major Business

Table 17. Mallinckrodt Radiopharmaceutical Therapy Product and Solutions

Table 18. Mallinckrodt Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Mallinckrodt Recent Developments and Future Plans

Table 20. Nordion Company Information, Head Office, and Major Competitors

Table 21. Nordion Major Business

Table 22. Nordion Radiopharmaceutical Therapy Product and Solutions

Table 23. Nordion Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. Nordion Recent Developments and Future Plans

Table 25. Triad Isotopes Company Information, Head Office, and Major Competitors

Table 26. Triad Isotopes Major Business

Table 27. Triad Isotopes Radiopharmaceutical Therapy Product and Solutions

Table 28. Triad Isotopes Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. Triad Isotopes Recent Developments and Future Plans

Table 30. Lantheus Company Information, Head Office, and Major Competitors

Table 31. Lantheus Major Business

Table 32. Lantheus Radiopharmaceutical Therapy Product and Solutions

Table 33. Lantheus Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Lantheus Recent Developments and Future Plans

Table 35. IBA Group Company Information, Head Office, and Major Competitors

Table 36. IBA Group Major Business

Table 37. IBA Group Radiopharmaceutical Therapy Product and Solutions

Table 38. IBA Group Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. IBA Group Recent Developments and Future Plans

Table 40. GE Healthcare Company Information, Head Office, and Major Competitors

Table 41. GE Healthcare Major Business

Table 42. GE Healthcare Radiopharmaceutical Therapy Product and Solutions

Table 43. GE Healthcare Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. GE Healthcare Recent Developments and Future Plans

Table 45. China Isotope & Radiation Company Information, Head Office, and Major Competitors

Table 46. China Isotope & Radiation Major Business

Table 47. China Isotope & Radiation Radiopharmaceutical Therapy Product and Solutions

Table 48. China Isotope & Radiation Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. China Isotope & Radiation Recent Developments and Future Plans

Table 50. Jubilant Pharma Company Information, Head Office, and Major Competitors

Table 51. Jubilant Pharma Major Business

Table 52. Jubilant Pharma Radiopharmaceutical Therapy Product and Solutions

Table 53. Jubilant Pharma Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Jubilant Pharma Recent Developments and Future Plans

Table 55. Eli Lilly Company Information, Head Office, and Major Competitors

Table 56. Eli Lilly Major Business

Table 57. Eli Lilly Radiopharmaceutical Therapy Product and Solutions

Table 58. Eli Lilly Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Eli Lilly Recent Developments and Future Plans

Table 60. Advanced Accelerator Applications Company Information, Head Office, and Major Competitors

Table 61. Advanced Accelerator Applications Major Business

Table 62. Advanced Accelerator Applications Radiopharmaceutical Therapy Product and Solutions

Table 63. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Advanced Accelerator Applications Recent Developments and Future Plans

Table 65. SIEMENS Company Information, Head Office, and Major Competitors

Table 66. SIEMENS Major Business

Table 67. SIEMENS Radiopharmaceutical Therapy Product and Solutions

Table 68. SIEMENS Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. SIEMENS Recent Developments and Future Plans

Table 70. Dongcheng Company Information, Head Office, and Major Competitors

Table 71. Dongcheng Major Business

Table 72. Dongcheng Radiopharmaceutical Therapy Product and Solutions

Table 73. Dongcheng Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. Dongcheng Recent Developments and Future Plans

Table 75. Navidea Company Information, Head Office, and Major Competitors

Table 76. Navidea Major Business

Table 77. Navidea Radiopharmaceutical Therapy Product and Solutions

Table 78. Navidea Radiopharmaceutical Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 79. Navidea Recent Developments and Future Plans

Table 80. Global Radiopharmaceutical Therapy Revenue (USD Million) by Players (2018-2023)

Table 81. Global Radiopharmaceutical Therapy Revenue Share by Players (2018-2023)

Table 82. Breakdown of Radiopharmaceutical Therapy by Company Type (Tier 1, Tier 2, and Tier 3)

Table 83. Market Position of Players in Radiopharmaceutical Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 84. Head Office of Key Radiopharmaceutical Therapy Players

Table 85. Radiopharmaceutical Therapy Market: Company Product Type Footprint

Table 86. Radiopharmaceutical Therapy Market: Company Product Application Footprint

Table 87. Radiopharmaceutical Therapy New Market Entrants and Barriers to Market Entry

Table 88. Radiopharmaceutical Therapy Mergers, Acquisition, Agreements, and Collaborations

Table 89. Global Radiopharmaceutical Therapy Consumption Value (USD Million) by Type (2018-2023)

Table 90. Global Radiopharmaceutical Therapy Consumption Value Share by Type (2018-2023)

Table 91. Global Radiopharmaceutical Therapy Consumption Value Forecast by Type (2024-2029)

Table 92. Global Radiopharmaceutical Therapy Consumption Value by Application (2018-2023)

Table 93. Global Radiopharmaceutical Therapy Consumption Value Forecast by Application (2024-2029)

Table 94. North America Radiopharmaceutical Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 95. North America Radiopharmaceutical Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 96. North America Radiopharmaceutical Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 97. North America Radiopharmaceutical Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 98. North America Radiopharmaceutical Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 99. North America Radiopharmaceutical Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 100. Europe Radiopharmaceutical Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 101. Europe Radiopharmaceutical Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 102. Europe Radiopharmaceutical Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 103. Europe Radiopharmaceutical Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 104. Europe Radiopharmaceutical Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 105. Europe Radiopharmaceutical Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 106. Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 107. Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 108. Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 109. Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 110. Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Region (2018-2023) & (USD Million)

Table 111. Asia-Pacific Radiopharmaceutical Therapy Consumption Value by Region (2024-2029) & (USD Million)

Table 112. South America Radiopharmaceutical Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 113. South America Radiopharmaceutical Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 114. South America Radiopharmaceutical Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 115. South America Radiopharmaceutical Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 116. South America Radiopharmaceutical Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 117. South America Radiopharmaceutical Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 118. Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 119. Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 120. Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 121. Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 122. Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 123. Middle East & Africa Radiopharmaceutical Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 124. Radiopharmaceutical Therapy Raw Material

Table 125. Key Suppliers of Radiopharmaceutical Therapy Raw Materials

List of Figures

Figure 1. Radiopharmaceutical Therapy Picture

Figure 2. Global Radiopharmaceutical Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Radiopharmaceutical Therapy Consumption Value Market Share by Type in 2022

Figure 4. Actinium-225

Figure 5. Lutetium-177

Figure 6. Radium-223

Figure 7. Holmium-166

Figure 8. Other

Figure 9. Global Radiopharmaceutical Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 10. Radiopharmaceutical Therapy Consumption Value Market Share by Application in 2022

Figure 11. Oncology Picture

Figure 12. Cardiology Picture

Figure 13. Other Picture

Figure 14. Global Radiopharmaceutical Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 15. Global Radiopharmaceutical Therapy Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 16. Global Market Radiopharmaceutical Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 17. Global Radiopharmaceutical Therapy Consumption Value Market Share by Region (2018-2029)

Figure 18. Global Radiopharmaceutical Therapy Consumption Value Market Share by Region in 2022

Figure 19. North America Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 20. Europe Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 21. Asia-Pacific Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 22. South America Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 23. Middle East and Africa Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 24. Global Radiopharmaceutical Therapy Revenue Share by Players in 2022

Figure 25. Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 26. Global Top 3 Players Radiopharmaceutical Therapy Market Share in 2022

Figure 27. Global Top 6 Players Radiopharmaceutical Therapy Market Share in 2022

Figure 28. Global Radiopharmaceutical Therapy Consumption Value Share by Type (2018-2023)

Figure 29. Global Radiopharmaceutical Therapy Market Share Forecast by Type (2024-2029)

Figure 30. Global Radiopharmaceutical Therapy Consumption Value Share by Application (2018-2023)

Figure 31. Global Radiopharmaceutical Therapy Market Share Forecast by Application (2024-2029)

Figure 32. North America Radiopharmaceutical Therapy Consumption Value Market Share by Type (2018-2029)

Figure 33. North America Radiopharmaceutical Therapy Consumption Value Market Share by Application (2018-2029)

Figure 34. North America Radiopharmaceutical Therapy Consumption Value Market Share by Country (2018-2029)

Figure 35. United States Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 36. Canada Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 37. Mexico Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 38. Europe Radiopharmaceutical Therapy Consumption Value Market Share by Type (2018-2029)

Figure 39. Europe Radiopharmaceutical Therapy Consumption Value Market Share by Application (2018-2029)

Figure 40. Europe Radiopharmaceutical Therapy Consumption Value Market Share by Country (2018-2029)

Figure 41. Germany Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 42. France Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 43. United Kingdom Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 44. Russia Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 45. Italy Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 46. Asia-Pacific Radiopharmaceutical Therapy Consumption Value Market Share by Type (2018-2029)

Figure 47. Asia-Pacific Radiopharmaceutical Therapy Consumption Value Market Share by Application (2018-2029)

Figure 48. Asia-Pacific Radiopharmaceutical Therapy Consumption Value Market Share by Region (2018-2029)

Figure 49. China Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 50. Japan Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 51. South Korea Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 52. India Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 53. Southeast Asia Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 54. Australia Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 55. South America Radiopharmaceutical Therapy Consumption Value Market Share by Type (2018-2029)

Figure 56. South America Radiopharmaceutical Therapy Consumption Value Market Share by Application (2018-2029)

Figure 57. South America Radiopharmaceutical Therapy Consumption Value Market Share by Country (2018-2029)

Figure 58. Brazil Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 59. Argentina Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 60. Middle East and Africa Radiopharmaceutical Therapy Consumption Value Market Share by Type (2018-2029)

Figure 61. Middle East and Africa Radiopharmaceutical Therapy Consumption Value Market Share by Application (2018-2029)

Figure 62. Middle East and Africa Radiopharmaceutical Therapy Consumption Value Market Share by Country (2018-2029)

Figure 63. Turkey Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 64. Saudi Arabia Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 65. UAE Radiopharmaceutical Therapy Consumption Value (2018-2029) & (USD Million)

Figure 66. Radiopharmaceutical Therapy Market Drivers

Figure 67. Radiopharmaceutical Therapy Market Restraints

Figure 68. Radiopharmaceutical Therapy Market Trends

Figure 69. Porters Five Forces Analysis

Figure 70. Manufacturing Cost Structure Analysis of Radiopharmaceutical Therapy in 2022

Figure 71. Manufacturing Process Analysis of Radiopharmaceutical Therapy

Figure 72. Radiopharmaceutical Therapy Industrial Chain

Figure 73. Methodology

Figure 74. Research Process and Data Source